

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.65701475 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.53014232 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.32256431 |
| 4 | neuronal action potential propagation (GO:0019227) | 5.23491596 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.19782294 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.05529275 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 5.04244816 |
| 8 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.02349711 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.95360790 |
| 10 | * gamma-aminobutyric acid transport (GO:0015812) | 4.94930411 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.84726930 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.74543009 |
| 13 | * neurotransmitter secretion (GO:0007269) | 4.71364676 |
| 14 | glutamate secretion (GO:0014047) | 4.65746018 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.62246893 |
| 16 | glutamate receptor signaling pathway (GO:0007215) | 4.42717647 |
| 17 | synaptic transmission, glutamatergic (GO:0035249) | 4.42358964 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.40937256 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.34707481 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.33041488 |
| 21 | axon ensheathment in central nervous system (GO:0032291) | 4.33029478 |
| 22 | central nervous system myelination (GO:0022010) | 4.33029478 |
| 23 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.29582496 |
| 24 | protein localization to synapse (GO:0035418) | 4.28300805 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.24647815 |
| 26 | presynaptic membrane assembly (GO:0097105) | 4.20603048 |
| 27 | postsynaptic membrane organization (GO:0001941) | 4.18900403 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.13424176 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.12843286 |
| 30 | cellular potassium ion homeostasis (GO:0030007) | 4.10572920 |
| 31 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.08870092 |
| 32 | potassium ion homeostasis (GO:0055075) | 3.96468105 |
| 33 | L-amino acid import (GO:0043092) | 3.95621395 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.94668099 |
| 35 | long-term memory (GO:0007616) | 3.93657581 |
| 36 | regulation of synaptic vesicle transport (GO:1902803) | 3.90115663 |
| 37 | proline transport (GO:0015824) | 3.88215479 |
| 38 | * neurotransmitter transport (GO:0006836) | 3.83460886 |
| 39 | presynaptic membrane organization (GO:0097090) | 3.83365026 |
| 40 | transmission of nerve impulse (GO:0019226) | 3.81048179 |
| 41 | cellular sodium ion homeostasis (GO:0006883) | 3.79033330 |
| 42 | layer formation in cerebral cortex (GO:0021819) | 3.77570651 |
| 43 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.77520005 |
| 44 | exploration behavior (GO:0035640) | 3.76336050 |
| 45 | startle response (GO:0001964) | 3.76065191 |
| 46 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.73322339 |
| 47 | response to auditory stimulus (GO:0010996) | 3.70244372 |
| 48 | positive regulation of dendritic spine development (GO:0060999) | 3.67991616 |
| 49 | C4-dicarboxylate transport (GO:0015740) | 3.67608405 |
| 50 | auditory behavior (GO:0031223) | 3.66262651 |
| 51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.61825917 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.60630841 |
| 53 | positive regulation of membrane potential (GO:0045838) | 3.60525043 |
| 54 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.60498812 |
| 55 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.60034028 |
| 56 | regulation of synapse maturation (GO:0090128) | 3.58821703 |
| 57 | cerebellar granule cell differentiation (GO:0021707) | 3.58351025 |
| 58 | sodium ion export (GO:0071436) | 3.58115418 |
| 59 | glycine transport (GO:0015816) | 3.57783620 |
| 60 | * regulation of neurotransmitter levels (GO:0001505) | 3.56547736 |
| 61 | alanine transport (GO:0032328) | 3.55642621 |
| 62 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.51924104 |
| 63 | synaptic vesicle endocytosis (GO:0048488) | 3.47740402 |
| 64 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.46942090 |
| 65 | * negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.46624110 |
| 66 | regulation of synapse structural plasticity (GO:0051823) | 3.46388693 |
| 67 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.45278563 |
| 68 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.41540502 |
| 69 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.39480916 |
| 70 | response to histamine (GO:0034776) | 3.36897999 |
| 71 | long-term synaptic potentiation (GO:0060291) | 3.34172470 |
| 72 | neuromuscular process controlling posture (GO:0050884) | 3.33437768 |
| 73 | cell communication by electrical coupling (GO:0010644) | 3.33399349 |
| 74 | mechanosensory behavior (GO:0007638) | 3.32707321 |
| 75 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.32628596 |
| 76 | regulation of postsynaptic membrane potential (GO:0060078) | 3.29153904 |
| 77 | positive regulation of synapse maturation (GO:0090129) | 3.27606088 |
| 78 | synapse assembly (GO:0007416) | 3.24991217 |
| 79 | succinate metabolic process (GO:0006105) | 3.23354240 |
| 80 | regulation of dendritic spine development (GO:0060998) | 3.23003667 |
| 81 | neuron recognition (GO:0008038) | 3.22643852 |
| 82 | striatum development (GO:0021756) | 3.21719920 |
| 83 | positive regulation of synapse assembly (GO:0051965) | 3.21213773 |
| 84 | regulation of synaptic plasticity (GO:0048167) | 3.20560936 |
| 85 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.20432597 |
| 86 | * amino acid import (GO:0043090) | 3.19366763 |
| 87 | regulation of neurotransmitter secretion (GO:0046928) | 3.15706228 |
| 88 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.15113403 |
| 89 | dendritic spine morphogenesis (GO:0060997) | 3.13152849 |
| 90 | establishment of mitochondrion localization (GO:0051654) | 3.12770090 |
| 91 | * regulation of synaptic transmission, GABAergic (GO:0032228) | 3.12073253 |
| 92 | membrane depolarization during action potential (GO:0086010) | 3.10248348 |
| 93 | adult walking behavior (GO:0007628) | 3.09703194 |
| 94 | neurotransmitter uptake (GO:0001504) | 3.09637220 |
| 95 | * acidic amino acid transport (GO:0015800) | 3.09271520 |
| 96 | L-glutamate transport (GO:0015813) | 3.09271520 |
| 97 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.09000857 |
| 98 | neuronal ion channel clustering (GO:0045161) | 3.05726615 |
| 99 | dicarboxylic acid catabolic process (GO:0043649) | 3.02743984 |
| 100 | potassium ion import (GO:0010107) | 3.02689990 |
| 101 | regulation of neurotransmitter transport (GO:0051588) | 3.02507039 |
| 102 | regulation of ARF protein signal transduction (GO:0032012) | 3.02253015 |
| 103 | * learning (GO:0007612) | 3.02094159 |
| 104 | neuromuscular synaptic transmission (GO:0007274) | 3.00688118 |
| 105 | membrane hyperpolarization (GO:0060081) | 3.00676027 |
| 106 | positive regulation of neurotransmitter transport (GO:0051590) | 2.99952132 |
| 107 | * synaptic transmission (GO:0007268) | 2.99536950 |
| 108 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.96141670 |
| 109 | positive regulation of synaptic transmission (GO:0050806) | 2.95460251 |
| 110 | nucleobase catabolic process (GO:0046113) | 2.95412115 |
| 111 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.92358687 |
| 112 | membrane depolarization (GO:0051899) | 2.92303898 |
| 113 | establishment of synaptic vesicle localization (GO:0097480) | 2.92275796 |
| 114 | synaptic vesicle transport (GO:0048489) | 2.92275796 |
| 115 | dendritic spine organization (GO:0097061) | 2.92262321 |
| 116 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.91585635 |
| 117 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.91182475 |
| 118 | regulation of vesicle fusion (GO:0031338) | 2.90949131 |
| 119 | neuromuscular process controlling balance (GO:0050885) | 2.90054253 |
| 120 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.89708144 |
| 121 | dendrite morphogenesis (GO:0048813) | 2.88525911 |
| 122 | dicarboxylic acid transport (GO:0006835) | 2.88010446 |
| 123 | * regulation of synaptic transmission (GO:0050804) | 2.87692139 |
| 124 | regulation of female receptivity (GO:0045924) | 2.86910731 |
| 125 | regulation of respiratory system process (GO:0044065) | 2.85669006 |
| 126 | detection of calcium ion (GO:0005513) | 2.85222496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.06892437 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.98773551 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.23359662 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21700340 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11252017 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69898323 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69898323 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.67444524 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.66428624 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65242632 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.61384609 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.56485904 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.53539652 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46887448 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.45792456 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41328011 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.23261022 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.22369916 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20313513 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19020278 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18352821 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16978014 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.07049198 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.04598641 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03523533 |
| 26 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.01916894 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99859142 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97332848 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91252872 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86411512 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85993763 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75840350 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74019113 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71064763 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70237695 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.67416885 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.66759775 |
| 38 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.65475031 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63699404 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.61110902 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56449734 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.54557215 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53195058 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50940294 |
| 45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46669663 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39650782 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38079507 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38036972 |
| 49 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37108816 |
| 50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36414620 |
| 51 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34502473 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34040096 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29527164 |
| 54 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28562105 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28407951 |
| 56 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28295012 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25586983 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24821535 |
| 59 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23646015 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21529065 |
| 61 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20190558 |
| 62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.19258229 |
| 63 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19115772 |
| 64 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17607900 |
| 65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14706022 |
| 66 | * AR_19668381_ChIP-Seq_PC3_Human | 1.14133923 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12643760 |
| 68 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.11663478 |
| 69 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11611887 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10150365 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10051310 |
| 72 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09836173 |
| 73 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09542986 |
| 74 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09477424 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05587064 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05405058 |
| 77 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05066155 |
| 78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03746652 |
| 79 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.01617444 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01273786 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00669865 |
| 82 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00087648 |
| 83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99948437 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99684163 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99402482 |
| 86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99215482 |
| 87 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98506858 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97279753 |
| 89 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97227013 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97198601 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 0.95486672 |
| 92 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.95174198 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94787800 |
| 94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94318933 |
| 95 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93917546 |
| 96 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.92904993 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92540364 |
| 98 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92177265 |
| 99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91970871 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91827236 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90974789 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90786988 |
| 103 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90646812 |
| 104 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90646812 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90088773 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90085796 |
| 107 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90041366 |
| 108 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89012034 |
| 109 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88959574 |
| 110 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88238712 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86892910 |
| 112 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.85937048 |
| 113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85044153 |
| 114 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.84905876 |
| 115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84180656 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83642824 |
| 117 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.83301884 |
| 118 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82622453 |
| 119 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82188541 |
| 120 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.78319948 |
| 121 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77301847 |
| 122 | KDM2B_26808549_Chip-Seq_REH_Human | 0.77020148 |
| 123 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.75552378 |
| 124 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.73679767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.38093191 |
| 2 | MP0003880_abnormal_central_pattern | 4.01163763 |
| 3 | MP0009046_muscle_twitch | 3.97755865 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 3.90092882 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.48151037 |
| 6 | MP0002064_seizures | 3.41385617 |
| 7 | MP0004270_analgesia | 3.06437262 |
| 8 | * MP0002063_abnormal_learning/memory/cond | 3.00565700 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.86106522 |
| 10 | MP0002272_abnormal_nervous_system | 2.74870673 |
| 11 | * MP0001486_abnormal_startle_reflex | 2.74605411 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.68736524 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.64858808 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.55639613 |
| 15 | MP0002822_catalepsy | 2.50846709 |
| 16 | MP0005646_abnormal_pituitary_gland | 2.32918196 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.29593922 |
| 18 | MP0002736_abnormal_nociception_after | 2.17378123 |
| 19 | MP0008569_lethality_at_weaning | 2.16758622 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.14156842 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.12953784 |
| 22 | MP0003136_yellow_coat_color | 2.09980438 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.08627539 |
| 24 | MP0004885_abnormal_endolymph | 2.04553683 |
| 25 | MP0002557_abnormal_social/conspecific_i | 1.94358448 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.91754451 |
| 27 | MP0001970_abnormal_pain_threshold | 1.91125828 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.89888280 |
| 29 | MP0001984_abnormal_olfaction | 1.85030666 |
| 30 | MP0001188_hyperpigmentation | 1.81469487 |
| 31 | MP0004142_abnormal_muscle_tone | 1.70933003 |
| 32 | MP0003329_amyloid_beta_deposits | 1.70235198 |
| 33 | MP0004858_abnormal_nervous_system | 1.68494682 |
| 34 | MP0000778_abnormal_nervous_system | 1.67194393 |
| 35 | MP0002184_abnormal_innervation | 1.63887304 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.59290833 |
| 37 | MP0004924_abnormal_behavior | 1.59290833 |
| 38 | MP0001502_abnormal_circadian_rhythm | 1.50471172 |
| 39 | MP0005171_absent_coat_pigmentation | 1.47920653 |
| 40 | MP0003787_abnormal_imprinting | 1.42897901 |
| 41 | MP0003690_abnormal_glial_cell | 1.41277960 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.40827336 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.40725005 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.40393621 |
| 45 | MP0000955_abnormal_spinal_cord | 1.39020343 |
| 46 | * MP0002066_abnormal_motor_capabilities/c | 1.38879316 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.38584818 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.38201394 |
| 49 | MP0004811_abnormal_neuron_physiology | 1.33889518 |
| 50 | MP0003879_abnormal_hair_cell | 1.31836258 |
| 51 | MP0003633_abnormal_nervous_system | 1.29559860 |
| 52 | MP0001905_abnormal_dopamine_level | 1.22543563 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.20876354 |
| 54 | MP0001529_abnormal_vocalization | 1.18560537 |
| 55 | MP0003631_nervous_system_phenotype | 1.16663523 |
| 56 | MP0003634_abnormal_glial_cell | 1.12546440 |
| 57 | MP0002229_neurodegeneration | 1.11322924 |
| 58 | MP0001963_abnormal_hearing_physiology | 1.11009950 |
| 59 | MP0001177_atelectasis | 1.10486287 |
| 60 | MP0002152_abnormal_brain_morphology | 1.09407738 |
| 61 | MP0004742_abnormal_vestibular_system | 1.04675135 |
| 62 | MP0005409_darkened_coat_color | 1.01765369 |
| 63 | MP0003122_maternal_imprinting | 1.01366934 |
| 64 | MP0003632_abnormal_nervous_system | 1.00867802 |
| 65 | MP0001485_abnormal_pinna_reflex | 0.98674122 |
| 66 | MP0004147_increased_porphyrin_level | 0.97752602 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.96400838 |
| 68 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96017081 |
| 69 | MP0004215_abnormal_myocardial_fiber | 0.95622121 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.95117523 |
| 71 | MP0000920_abnormal_myelination | 0.94343301 |
| 72 | MP0002139_abnormal_hepatobiliary_system | 0.92805246 |
| 73 | MP0000013_abnormal_adipose_tissue | 0.91071199 |
| 74 | MP0003646_muscle_fatigue | 0.89624326 |
| 75 | MP0000566_synostosis | 0.87582836 |
| 76 | MP0000631_abnormal_neuroendocrine_gland | 0.85584181 |
| 77 | MP0003137_abnormal_impulse_conducting | 0.84606862 |
| 78 | MP0002752_abnormal_somatic_nervous | 0.84292042 |
| 79 | MP0005535_abnormal_body_temperature | 0.82023147 |
| 80 | MP0000751_myopathy | 0.81683369 |
| 81 | MP0000026_abnormal_inner_ear | 0.80331518 |
| 82 | * MP0002069_abnormal_eating/drinking_beha | 0.79490081 |
| 83 | MP0005623_abnormal_meninges_morphology | 0.79148208 |
| 84 | MP0005394_taste/olfaction_phenotype | 0.77273072 |
| 85 | MP0005499_abnormal_olfactory_system | 0.77273072 |
| 86 | MP0002090_abnormal_vision | 0.76904943 |
| 87 | MP0004130_abnormal_muscle_cell | 0.75815485 |
| 88 | MP0004085_abnormal_heartbeat | 0.75636114 |
| 89 | MP0008872_abnormal_physiological_respon | 0.74104473 |
| 90 | MP0010386_abnormal_urinary_bladder | 0.74056481 |
| 91 | MP0004043_abnormal_pH_regulation | 0.71012710 |
| 92 | MP0004233_abnormal_muscle_weight | 0.69274373 |
| 93 | MP0008874_decreased_physiological_sensi | 0.68574006 |
| 94 | MP0003123_paternal_imprinting | 0.68475264 |
| 95 | MP0001299_abnormal_eye_distance/ | 0.68195877 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.66748519 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 0.66440791 |
| 98 | MP0005253_abnormal_eye_physiology | 0.65785171 |
| 99 | MP0001664_abnormal_digestion | 0.64662234 |
| 100 | MP0000604_amyloidosis | 0.64598866 |
| 101 | MP0001943_abnormal_respiration | 0.62012240 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 0.61588300 |
| 103 | MP0009384_cardiac_valve_regurgitation | 0.60975083 |
| 104 | MP0005595_abnormal_vascular_smooth | 0.60954590 |
| 105 | MP0006292_abnormal_olfactory_placode | 0.60848523 |
| 106 | MP0005365_abnormal_bile_salt | 0.60788206 |
| 107 | MP0005187_abnormal_penis_morphology | 0.60777269 |
| 108 | MP0004145_abnormal_muscle_electrophysio | 0.60218406 |
| 109 | MP0003868_abnormal_feces_composition | 0.60141329 |
| 110 | MP0002249_abnormal_larynx_morphology | 0.59657752 |
| 111 | MP0001346_abnormal_lacrimal_gland | 0.59240271 |
| 112 | MP0003075_altered_response_to | 0.57126144 |
| 113 | MP0010769_abnormal_survival | 0.56384238 |
| 114 | MP0004484_altered_response_of | 0.55703922 |
| 115 | MP0003938_abnormal_ear_development | 0.55466029 |
| 116 | MP0010770_preweaning_lethality | 0.54333160 |
| 117 | MP0002082_postnatal_lethality | 0.54333160 |
| 118 | MP0010768_mortality/aging | 0.52681955 |
| 119 | MP0010329_abnormal_lipoprotein_level | 0.52313834 |
| 120 | MP0000639_abnormal_adrenal_gland | 0.50535002 |
| 121 | MP0003861_abnormal_nervous_system | 0.50300501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.57713468 |
| 2 | Atonic seizures (HP:0010819) | 5.72847072 |
| 3 | Febrile seizures (HP:0002373) | 5.56951844 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.52598948 |
| 5 | Focal seizures (HP:0007359) | 5.49773851 |
| 6 | Myokymia (HP:0002411) | 5.05582420 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.42977689 |
| 8 | Absence seizures (HP:0002121) | 4.27372691 |
| 9 | Visual hallucinations (HP:0002367) | 4.05091783 |
| 10 | Hyperventilation (HP:0002883) | 4.03981860 |
| 11 | Dialeptic seizures (HP:0011146) | 3.95466916 |
| 12 | Hemiparesis (HP:0001269) | 3.80863393 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.80696710 |
| 14 | Abnormality of binocular vision (HP:0011514) | 3.80554405 |
| 15 | Diplopia (HP:0000651) | 3.80554405 |
| 16 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.69087176 |
| 17 | Aplasia of the phalanges of the hand (HP:0009802) | 3.69087176 |
| 18 | Aplasia involving bones of the extremities (HP:0009825) | 3.69087176 |
| 19 | Gaze-evoked nystagmus (HP:0000640) | 3.61371319 |
| 20 | Hemiplegia (HP:0002301) | 3.60878056 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.48907012 |
| 22 | Urinary urgency (HP:0000012) | 3.36499928 |
| 23 | Action tremor (HP:0002345) | 3.31458905 |
| 24 | Abnormal eating behavior (HP:0100738) | 3.25727567 |
| 25 | Megalencephaly (HP:0001355) | 3.17644088 |
| 26 | Truncal ataxia (HP:0002078) | 3.16968024 |
| 27 | Broad-based gait (HP:0002136) | 3.15143850 |
| 28 | Progressive inability to walk (HP:0002505) | 3.13198168 |
| 29 | Papilledema (HP:0001085) | 3.05937962 |
| 30 | Status epilepticus (HP:0002133) | 3.05226301 |
| 31 | Peripheral hypomyelination (HP:0007182) | 3.01267827 |
| 32 | Cerebral hypomyelination (HP:0006808) | 3.00459226 |
| 33 | Abnormality of the corticospinal tract (HP:0002492) | 2.90032877 |
| 34 | Obstructive sleep apnea (HP:0002870) | 2.88057563 |
| 35 | Focal dystonia (HP:0004373) | 2.86995559 |
| 36 | Lower limb muscle weakness (HP:0007340) | 2.84366914 |
| 37 | Tetraplegia (HP:0002445) | 2.81788482 |
| 38 | Depression (HP:0000716) | 2.78737699 |
| 39 | Supranuclear gaze palsy (HP:0000605) | 2.77352526 |
| 40 | Clonus (HP:0002169) | 2.76656524 |
| 41 | Scanning speech (HP:0002168) | 2.75981928 |
| 42 | Dysmetria (HP:0001310) | 2.71835807 |
| 43 | Impaired social interactions (HP:0000735) | 2.69929688 |
| 44 | Abnormal social behavior (HP:0012433) | 2.69929688 |
| 45 | Polyphagia (HP:0002591) | 2.67317895 |
| 46 | Poor eye contact (HP:0000817) | 2.64184930 |
| 47 | Anxiety (HP:0000739) | 2.63169377 |
| 48 | Pheochromocytoma (HP:0002666) | 2.61965888 |
| 49 | Delusions (HP:0000746) | 2.60710176 |
| 50 | Craniofacial dystonia (HP:0012179) | 2.59421368 |
| 51 | Genetic anticipation (HP:0003743) | 2.58414055 |
| 52 | Akinesia (HP:0002304) | 2.58134598 |
| 53 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.52444922 |
| 54 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.52444922 |
| 55 | Neurofibrillary tangles (HP:0002185) | 2.48377923 |
| 56 | Blue irides (HP:0000635) | 2.47993124 |
| 57 | Split foot (HP:0001839) | 2.44759846 |
| 58 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.44054802 |
| 59 | Postural instability (HP:0002172) | 2.42963477 |
| 60 | Abnormality of the lower motor neuron (HP:0002366) | 2.39180294 |
| 61 | Gait imbalance (HP:0002141) | 2.38411352 |
| 62 | Ankle clonus (HP:0011448) | 2.37159586 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.33967929 |
| 64 | Neuroendocrine neoplasm (HP:0100634) | 2.32061681 |
| 65 | Narrow nasal bridge (HP:0000446) | 2.28458790 |
| 66 | Generalized myoclonic seizures (HP:0002123) | 2.28006840 |
| 67 | Drooling (HP:0002307) | 2.27902940 |
| 68 | Excessive salivation (HP:0003781) | 2.27902940 |
| 69 | EEG with generalized epileptiform discharges (HP:0011198) | 2.24689585 |
| 70 | Spastic tetraparesis (HP:0001285) | 2.23706510 |
| 71 | Humeroradial synostosis (HP:0003041) | 2.22046650 |
| 72 | Synostosis involving the elbow (HP:0003938) | 2.22046650 |
| 73 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.21793563 |
| 74 | Mutism (HP:0002300) | 2.21370084 |
| 75 | Absent speech (HP:0001344) | 2.20440985 |
| 76 | Hypsarrhythmia (HP:0002521) | 2.20418445 |
| 77 | Limb dystonia (HP:0002451) | 2.18672482 |
| 78 | Inability to walk (HP:0002540) | 2.16723973 |
| 79 | Intention tremor (HP:0002080) | 2.16372404 |
| 80 | Apathy (HP:0000741) | 2.14766678 |
| 81 | Increased circulating renin level (HP:0000848) | 2.11636675 |
| 82 | Rigidity (HP:0002063) | 2.10331825 |
| 83 | Annular pancreas (HP:0001734) | 2.10166641 |
| 84 | Bradykinesia (HP:0002067) | 2.08300430 |
| 85 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.07433158 |
| 86 | Congenital primary aphakia (HP:0007707) | 2.07175492 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.06442997 |
| 88 | Abnormal hair whorl (HP:0010721) | 2.05786209 |
| 89 | Fetal akinesia sequence (HP:0001989) | 2.03728113 |
| 90 | Impaired smooth pursuit (HP:0007772) | 2.03275120 |
| 91 | Hypoplastic left heart (HP:0004383) | 2.02665468 |
| 92 | Medial flaring of the eyebrow (HP:0010747) | 2.01533017 |
| 93 | Choreoathetosis (HP:0001266) | 2.00476510 |
| 94 | Specific learning disability (HP:0001328) | 1.99450284 |
| 95 | Thickened helices (HP:0000391) | 1.98918206 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 1.96674385 |
| 97 | Amyotrophic lateral sclerosis (HP:0007354) | 1.95741946 |
| 98 | Clumsiness (HP:0002312) | 1.94702299 |
| 99 | Diminished motivation (HP:0000745) | 1.93812804 |
| 100 | Incomplete penetrance (HP:0003829) | 1.92868561 |
| 101 | CNS hypomyelination (HP:0003429) | 1.92528935 |
| 102 | Dysmetric saccades (HP:0000641) | 1.92229177 |
| 103 | Gait ataxia (HP:0002066) | 1.91989475 |
| 104 | Nephrogenic diabetes insipidus (HP:0009806) | 1.91164463 |
| 105 | Insomnia (HP:0100785) | 1.91032172 |
| 106 | Stereotypic behavior (HP:0000733) | 1.89846591 |
| 107 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.89687307 |
| 108 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.88665633 |
| 109 | Limb ataxia (HP:0002070) | 1.86270018 |
| 110 | Rapidly progressive (HP:0003678) | 1.85763304 |
| 111 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.83049550 |
| 112 | Cerebral inclusion bodies (HP:0100314) | 1.82850090 |
| 113 | Agitation (HP:0000713) | 1.82529505 |
| 114 | Deep venous thrombosis (HP:0002625) | 1.81613505 |
| 115 | Bronchomalacia (HP:0002780) | 1.78420365 |
| 116 | Hyperthyroidism (HP:0000836) | 1.78044194 |
| 117 | Spastic gait (HP:0002064) | 1.75929642 |
| 118 | Complement deficiency (HP:0004431) | 1.75322043 |
| 119 | Sleep apnea (HP:0010535) | 1.75034257 |
| 120 | Impaired vibratory sensation (HP:0002495) | 1.74747099 |
| 121 | Hypoplasia of the corpus callosum (HP:0002079) | 1.74549721 |
| 122 | Amblyopia (HP:0000646) | 1.74326636 |
| 123 | Failure to thrive in infancy (HP:0001531) | 1.72981787 |
| 124 | Cortical visual impairment (HP:0100704) | 1.72832806 |
| 125 | Spinal canal stenosis (HP:0003416) | 1.71513828 |
| 126 | Abnormality of saccadic eye movements (HP:0000570) | 1.71405523 |
| 127 | Poor suck (HP:0002033) | 1.70581870 |
| 128 | Torticollis (HP:0000473) | 1.69566230 |
| 129 | Vaginal atresia (HP:0000148) | 1.69519415 |
| 130 | Genital tract atresia (HP:0001827) | 1.69195970 |
| 131 | Psychosis (HP:0000709) | 1.67483974 |
| 132 | Spastic tetraplegia (HP:0002510) | 1.66293483 |
| 133 | Horizontal nystagmus (HP:0000666) | 1.65137168 |
| 134 | Mixed hearing impairment (HP:0000410) | 1.64678045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.92506435 |
| 2 | CASK | 3.81196268 |
| 3 | TNIK | 3.70945580 |
| 4 | MAP2K7 | 3.49721138 |
| 5 | EPHA4 | 3.33696496 |
| 6 | MAP3K4 | 3.14256155 |
| 7 | NTRK2 | 2.99748950 |
| 8 | MARK1 | 2.72201431 |
| 9 | MINK1 | 2.23271971 |
| 10 | MAP3K9 | 2.20336317 |
| 11 | MUSK | 2.07748447 |
| 12 | MAP3K12 | 1.92708806 |
| 13 | FES | 1.85730640 |
| 14 | PRPF4B | 1.78580686 |
| 15 | MAP2K4 | 1.68038640 |
| 16 | PHKG1 | 1.62893547 |
| 17 | PHKG2 | 1.62893547 |
| 18 | PRKD3 | 1.58035150 |
| 19 | MKNK2 | 1.57613316 |
| 20 | PRKCG | 1.53652091 |
| 21 | MAPK13 | 1.52224938 |
| 22 | PAK6 | 1.45952899 |
| 23 | CDK5 | 1.40554386 |
| 24 | DAPK2 | 1.38619964 |
| 25 | SGK2 | 1.31683871 |
| 26 | ERBB4 | 1.30605413 |
| 27 | NTRK1 | 1.28890929 |
| 28 | RIPK1 | 1.26941397 |
| 29 | SGK223 | 1.26897020 |
| 30 | SGK494 | 1.26897020 |
| 31 | CAMKK1 | 1.23341153 |
| 32 | STK38 | 1.18430951 |
| 33 | PLK2 | 1.18228057 |
| 34 | GRK5 | 1.15509808 |
| 35 | CDK19 | 1.15141452 |
| 36 | LATS2 | 1.10727857 |
| 37 | AKT3 | 1.07207248 |
| 38 | PRKCE | 1.06982618 |
| 39 | CAMKK2 | 1.06217208 |
| 40 | SIK2 | 1.05557378 |
| 41 | LMTK2 | 1.04411978 |
| 42 | PINK1 | 1.04237465 |
| 43 | CAMK2A | 1.04088885 |
| 44 | UHMK1 | 1.01546233 |
| 45 | PNCK | 0.99464445 |
| 46 | SGK3 | 0.95103001 |
| 47 | NEK6 | 0.92216243 |
| 48 | DAPK1 | 0.88864462 |
| 49 | OXSR1 | 0.87513251 |
| 50 | KSR1 | 0.87345271 |
| 51 | RIPK4 | 0.86240125 |
| 52 | CAMK2B | 0.84280069 |
| 53 | DYRK1A | 0.81709897 |
| 54 | CDK18 | 0.79084377 |
| 55 | CDK14 | 0.78606631 |
| 56 | CAMK1 | 0.78115402 |
| 57 | CDK15 | 0.77890535 |
| 58 | PDK4 | 0.77010780 |
| 59 | PDK3 | 0.77010780 |
| 60 | PRKCH | 0.76857518 |
| 61 | TNK2 | 0.76641040 |
| 62 | ARAF | 0.74389867 |
| 63 | SGK1 | 0.74055925 |
| 64 | CAMK4 | 0.72332226 |
| 65 | TYRO3 | 0.72283014 |
| 66 | STK11 | 0.71503136 |
| 67 | MAPK12 | 0.71043176 |
| 68 | KSR2 | 0.70924308 |
| 69 | WNK1 | 0.70422876 |
| 70 | CSNK1G2 | 0.67081854 |
| 71 | CAMK2G | 0.66810307 |
| 72 | CDK11A | 0.66423324 |
| 73 | FER | 0.65772464 |
| 74 | PKN1 | 0.63943130 |
| 75 | LIMK1 | 0.63181225 |
| 76 | CDK8 | 0.58185752 |
| 77 | DYRK2 | 0.58179408 |
| 78 | WNK3 | 0.57302104 |
| 79 | RAF1 | 0.55583677 |
| 80 | CSNK1A1L | 0.55517921 |
| 81 | CSNK1G3 | 0.55079935 |
| 82 | CAMK2D | 0.54885155 |
| 83 | TSSK6 | 0.54711254 |
| 84 | ALK | 0.51807656 |
| 85 | PDK1 | 0.51540171 |
| 86 | RPS6KA3 | 0.50553198 |
| 87 | RET | 0.49662075 |
| 88 | TESK1 | 0.46807137 |
| 89 | BCR | 0.46802727 |
| 90 | FYN | 0.46323830 |
| 91 | BMPR2 | 0.46272830 |
| 92 | MARK2 | 0.45403625 |
| 93 | FGR | 0.44916259 |
| 94 | PRKACA | 0.44205869 |
| 95 | MAP3K13 | 0.43788041 |
| 96 | PAK3 | 0.43686942 |
| 97 | FGFR2 | 0.43445595 |
| 98 | NME1 | 0.43161933 |
| 99 | ROCK2 | 0.42922855 |
| 100 | PRKCZ | 0.42909932 |
| 101 | PDK2 | 0.41542480 |
| 102 | MAPK7 | 0.41154820 |
| 103 | CSNK1D | 0.40241218 |
| 104 | CDK3 | 0.40060551 |
| 105 | PRKCA | 0.39540666 |
| 106 | BRSK1 | 0.39458950 |
| 107 | DAPK3 | 0.39048289 |
| 108 | PRKG1 | 0.38284355 |
| 109 | ERBB2 | 0.37899326 |
| 110 | CDC42BPA | 0.37768849 |
| 111 | ADRBK2 | 0.37724672 |
| 112 | MAPK10 | 0.37556124 |
| 113 | PDPK1 | 0.36746431 |
| 114 | CSNK1G1 | 0.36451362 |
| 115 | MKNK1 | 0.36402380 |
| 116 | PRKCB | 0.35408471 |
| 117 | CCNB1 | 0.35331508 |
| 118 | MAP4K2 | 0.35121440 |
| 119 | CSNK1A1 | 0.34580132 |
| 120 | ROCK1 | 0.34108998 |
| 121 | MAPKAPK5 | 0.30625987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.48151663 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.39686252 |
| 3 | * GABAergic synapse_Homo sapiens_hsa04727 | 3.25169939 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.19501235 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.88554465 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.69752582 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.60672806 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46271233 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.30371031 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.21603371 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.00873216 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.00066339 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.95100450 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.94585884 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.86383753 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.84427692 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.81487209 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.75075391 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.74876347 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64334846 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63473260 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.55001986 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52854919 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49303202 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49131862 |
| 26 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.42961744 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40742699 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40040337 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.32727587 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.32170129 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.30609561 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.27927109 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25842359 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20123001 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18330500 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.17494534 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14614716 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.12582149 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12187398 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09998561 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.07515117 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.00528407 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.00126519 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99324235 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99134822 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98918061 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97905544 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96732106 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95417089 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 0.91613039 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.90930283 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89555984 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83712371 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82898333 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82465673 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82457372 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80558560 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79735652 |
| 59 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78482469 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78207238 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76573967 |
| 62 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75032663 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73989751 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70691356 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69561869 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68888633 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68497992 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66905758 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65084984 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64874108 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.64729091 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64476568 |
| 73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64416273 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62392466 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59570683 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57804209 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56916846 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54835432 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54717079 |
| 80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54247852 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53272256 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52999679 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.50251513 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50119761 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49945568 |
| 86 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49680220 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49141262 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48783897 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45273615 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44548886 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44460400 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44123713 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43015255 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42929791 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42887241 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42637228 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41523247 |
| 98 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41316718 |
| 99 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.39976851 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.39703647 |
| 101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39648491 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39409801 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38899322 |
| 104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38459864 |
| 105 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38329710 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37304926 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36984047 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35658984 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35213118 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35015390 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34834177 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34699059 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34045269 |
| 114 | Melanoma_Homo sapiens_hsa05218 | 0.32951819 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32622565 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32402147 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.31568674 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.30144856 |
| 119 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.27749478 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27209785 |
| 121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27036873 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24590973 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.23871057 |

